Previously recorded as Invitrogen Corporation (to 2009)
Previously recorded as Biotrove, Inc. (to 2018)
1,519 patents currently held
33 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
151 more records may belong here and await a decision; they are not counted.
The next term ends in Nov 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
317
Ending by 2030
Nov 2026
Next term end
740
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends no later than Sep 2033 · Medium confidence
Also notable
Ends May 2030 · High confidence
Also notable
Ends Jan 2029 · High confidence
Also notable
Ends Feb 2035 · High confidence
Also notable
Ends Mar 2028 · High confidence
Also notable
Ends Apr 2035 · High confidence
Also notable
Ends Jun 2033 · High confidence
Also notable
Ends Apr 2028 · Medium confidence
Methods and Compositions for Multiplex PCR
US 9,957,558
Cited by 372 later US patents, top 1% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2033. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Fluidics System for Sequential Delivery of Reagents
US 8,546,128
Cited by 342 later US patents, top 1% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Methods and Apparatus for Measuring Analytes Using Large Scale Fet Arrays
US 7,948,015
Cited by 435 later US patents, top 1% of utility patents granted in 2011 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Methods, Systems, and Computer Readable Media for Nucleic Acid Sequencing
US 10,241,075
Cited by 289 later US patents, top 1% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2035.
Gas Spargers and Related Container Systems
US 8,603,805
Cited by 233 later US patents, top 5% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028.
Gene Fusions and Gene Variants Associated with Cancer
US 10,072,298
Cited by 95 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
Hydrophilic Polymeric Particles and Methods for Making and Using Same
US 9,243,085
Cited by 129 later US patents, top 5% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Particle Quantifying Systems and Methods Using Acoustic Radiation Pressure
US 8,309,408
Cited by 159 later US patents, top 5% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2028.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 26, 2026The maintenance fee for Methods and Apparatus for Detecting Molecular Interactions Using Fet Arrays (US 9,039,888) comes due Nov 26, 2026. Unpaid by May 26, 2027, it lapses early.
- 22 fees due Dec 2 to 30, 2026 · next Dec 2
- 24 fees due Jan 2 to 30, 2027 · next Jan 2
- 26 fees due Feb 1 to 28, 2027 · next Feb 1
- 38 fees due Mar 1 to 29, 2027 · next Mar 1
- 26 fees due Apr 1 to 30, 2027 · next Apr 1
- 25 fees due May 3 to 26, 2027 · next May 3
- 16 fees due Jun 3 to 30, 2027 · next Jun 3
- 24 fees due Jul 2 to 30, 2027 · next Jul 2
- 24 fees due Aug 2 to 27, 2027 · next Aug 2
- 20 fees due Sep 1 to 30, 2027 · next Sep 1
- 32 fees due Oct 2 to 30, 2027 · next Oct 2
- 11 fees due Nov 5 to 19, 2027 · next Nov 5
Recent changes
- Nov 16Assignment recorded on 1 record: Potter, Robert to Life Technologies Corporation Recorded Nov 16, 2026, executed Mar 2, 2021. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76769, frame 328.
- Nov 6Assignment recorded on 1 record: Reed, Mark and 3 others to Life Technologies Corporation Recorded Nov 6, 2026, executed Aug 14, 2019. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76661, frame 963.
- 18 of the patents on this record were granted since Aug 23, 2026
- 17 terms have ended since Aug 23, 2026
- Nov 17 US 7,556,858 Substrate with Attached Dendrimers · term ended
- Oct 31 US 7,850,835 Solution Phase Electrophoresis Device, Components, and Methods · term ended
- Oct 19 US 7,638,049 Three-Port High Performance Mini Hollow Fiber Membrane Contactor · term ended
- Oct 17 US 8,133,709 Target Sequences for Synthetic Molecules · term ended
- Oct 16 US D669,155 Filter System · term ended
- Oct 16 US 10,100,248 Magnesium-Based Coatings for Nanocrystals · lapsed on the fee record
- Oct 9 US D668,718 Label · term ended
- Oct 9 US D668,699 Digital Microscope · term ended
- Sep 26 US 8,415,477 Violet Laser Excitable Dyes and Their Method of Use · term ended
- Sep 25 US 10,081,833 Methods, Compositions, and Kits for Detecting Allelic Variants · lapsed on the fee record
- Sep 15 US 10,753,905 Isotopically-Labeled Proteome Standards · term ended
- Sep 13 US 7,749,388 Low Volume Filtration Column Devices and Methods of Filtering Therewith · term ended
- Sep 11 US D667,134 Electrophoresis Apparatus · term ended
- Sep 7 US 7,727,716 Detection of Immobilized Nucleic Acid · term ended
- Sep 4 US D666,737 Electrophoresis Device · term ended
What they patent
The largest of its 740 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,598,390 | Fluorescent Chemical Compounds Having High Selectivity for Double Stranded DNA, and Methods for Their Use In force · High confidence | In force | High confidence | |
| US 7,811,507 | Dialysis Membrane Having Improved Ability for Removal of Middle Molecules In force · Medium confidence | In force | Medium confidence | |
| US D673,243 | Filtration Capsule In force · High confidence | In force | High confidence | |
| US 9,057,694 | Compositions and Methods for Improving Resolution of Biomolecules Separated on Polyacrylamide Gels In force · High confidence | In force | High confidence | |
| US 7,413,660 | Single Pass Method and Apparatus for Separating a Target Molecule from a Liquid Mixture In force · High confidence | In force | High confidence | |
| US 9,376,698 | Mutant DNA Polymerases In force · High confidence | In force | High confidence | |
| US 9,964,490 | Device and Methods for Quantifying Analytes In force · Medium confidence | In force | Medium confidence | |
| US 10,962,480 | Device and Methods for Quantifying Analytes Introduction In force · Low confidence | In force | Low confidence | |
| US 11,635,383 | Device and Methods for Quantifying Analytes Introduction In force · Low confidence | In force | Low confidence | |
| US 12,487,180 | Device and Methods for Quantifying Analytes Introduction In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 1,519: 33 patents in force now held by others · 446 patents ended · 358 applications pending · 984 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.